WHO Register of non-State actors

Disclaimer:

Information regarding a non-State actor, contained in the section “Non-State Actors Profiles” in the Register, has been provided by that non-State actor itself, and the accuracy and completeness of such information is the sole responsibility of that non-State actor, not WHO. In turn, information in the sections “WHO’s Engagement” and “Non-State Actors in Official Relations” has been provided by WHO, subject to certain conditions. All access and use of any section of the Register is governed by the Terms and Conditions of Use.

Overview

Official name

International Society of Radiology

Acronym (if applicable)

ISR

Short self description

The International Society of Radiology (ISR) is a confederation of national and continental radiological societies. Its mission is defined broadly as education in radiology, the advancement of the practice, radiation science and protection.

Website

http://www.isradiology.org

Web link to health relevant activities

Parent entity (if applicable)

The entity you represent is indicated as a parent of the following entities in the Register:

N / A

Date submitted

04 Sep 2024 01:26:44 PM

General information

Name

Official name

International Society of Radiology

Acronym (if applicable)

ISR

Commonly used name (if applicable)

Names in other official languages (if applicable) Name Abbreviation

International Society of Radiology

ISR

Former name

Short self description

Address

Address 1

1891 Preston White Drive

Address 2

Address 3

Town/City

Reston

State/Region

Postal code

20191

Country

United States of America

Related links

Website

http://www.isradiology.org

Governance

Legal status

Non-profit organisation

Year established

1953

Governance structure

Description of main decision making bodies (e.g. board, board of directors, executive board, executive committee, etc).

Name of body

Executive Committee

Composition and current list of members Name Function Affiliation

Dr. Bibb Allen

President

3245 East Briarcliff Road Birmingham, AL 35223 UNITED STATES OF AMERICA

Dr. Sudhir Vinayak

President-Elect

Aga Khan University Hospital Radiology PO Box 30270 - GPO 00100 Nairobi KENYA

Dr. Renato Mendonça

Past-President

DASA Radiology 05688000 Sao Paulo BRAZIL

Dr. Boris Brkljačić

Secretary General

University Hospital Dubrava Medical School, University of Zagreb Avenija G. Suska 6 10000 Zagreb CROATIA

Dr. Beatriz E. González Ulloa

Treasurer

Zapopan, MEXICO

Dr. Alan H. Matsumoto

Continental Member, ACR

1891 Preston White Drive Reston, VA 20191, UNITED STATES OF AMERICA

Dr. Noriyuki Tomiyama

Continental Member, AOSR

Japan

Dr. Tarek El Diasty

Continental Member, ASR

Urology and Nephrology Center Mansoura University, Radiology Dept. El-Gomhoreia St. 35516 Mansoura EGYPT

Dr. Luis Campos

Continental Member, CIR

Dominican Republic

Dr. Adrian P. Brady

Continental Member, ESR

Mercy University Hospital Grenville Place Cork, T12 WE28, Ireland

Dr. Umar Mahmood

Continental Member, RSNA

Radiological Society of North America, Inc. 820 Jorie Blvd., Suite 200 60523-2251 Oak Brook UNITED STATES OF AMERICA

Dr. Lamia Jamjoom

Regional Member, PAARS

KSA King Abdul Aziz University, Jeddah SAUDI ARABIA

Dr. Jean-Pierre Tasu

Elected Member

France

Dr. Emad Shenouda Naguib

Elected Member

AlSalam Hospital Radiology Department 3 Syria Street Giza EGYPT

Dr. Whal Lee

Elected Member

Seoul National University Hospital, Republic of Korea

Dr. Antonia Arjonilla

Elected Member

Spain

Dr. Edward Mwansa

Elected Member

Zambia

Dr. Guy Frija

Co-Chair ISRQSA

Department of Radiology HEGP Université René Descartes 20-40 Rue Leblanc Paris, 75015 FRANCE

Dr. Donald P. Frush

Co-Chair ISRQSA

Duke Medical Center 2301 Erwin Rd Durham, NC 27705 UNITED STATES OF AMERICA

Dr. Geraldine McGinty

Chair ISRCRE

Weill Cornell Medicine New York, NY UNITED STATES OF AMERICA

Dr. Jose Luis del Cura

Chair Communucations Working Group

Hospital Universitario Donostia Radiology Department 20014 Donostia-San Sebastian SPAIN

Functions

The Executive Committee is the executive decision-making body of the ISR.

Name of body

Composition and current list of members Name Function Affiliation

Functions

General Assembly

Does the entity have a General Assembly of members or a similar body?

Yes

Name

International Assembly

Composition

The International Assembly consists of the national delegations of member
countries which dues are current, together with the Executive Committee.

Functions

The International Assembly approves broad policies and official actions of the
ISR.

Financial information

Latest available annual income (month/year)

From

January

2023

December

2023

Annual income (USD)

100,193

Latest available assets (month/year)

As of

December

2023

Total assets (USD)

1,527,513

Income sources (in USD)

Income source Income type

Private sector entities (including business associations)

Philanthropic foundations

NGOs, academic institutions

Government entities, intergovernmental organizations, including UN

General public, individuals

Total

Sales of goods and services *

Grants / Donations

In-kind donations

Membership fees

62,406

Investment income

37,787

Others

Total

37,787

62,406

100,193

* income from congresses / conferences should be listed under Sales of goods and services

Additional information

Membership

Entity's members

Is the entity you represent membership based?

Yes

Overview of categories and their voting rights in the main governing body:

Total number Voting

Individuals

NGOs

Private sector entities

Philanthropic foundations

Academic institutions

Government entities

Intergovernmental organizations

Organizational Structure

Parent entity

In the register Registered Entity Entity Name

No data available

Yes

Legal status

Affiliated entities (or subsidiaries)

In the register Registered Entity Entity Name

No data available

Relations

Entity's membership in other entities

In the register Registered Entity Entity Name Type of membership

No data available

Members of the entity

In the register Registered Entity Member Name

No data available

Activities

Aims (or purposes, objectives) of the entity as they appear in its constitution or by-laws or equivalent document.

SCOPE: The scope of the ISR comprises all branches of diagnostic radiology including x-ray, sonography, magnetic resonance imaging and spectroscopy, and interventional radiology, nuclear medicine, and biology and physics as related to medical imaging

PURPOSES
The ISR shall be a nonprofit organization whose objectives are the following:

A. As a representative nongovernmental organization (NGO) to facilitate the global endeavors of the ISR’s member organizations to improve patient care and population health through medical imaging.

B. To accept, hold, invest, and administer any property – real, personal, or mixed – by gift, devise, bequest, purchase, lease, loan, or otherwise, absolutely or in trust, for any of the foregoing purposes and carry out the directions and exercise the powers contained in any trust or other instrument under which such property may be received, including, but without limitation, the expenditure of the principal, as well as the income, of any property so received, if authorized or directed in such trust or other instrument. If any such property is received without any designation of specific use, the ISR shall expend the income and principal thereof for any one or more of the foregoing purposes in such manner and amounts and at such time or times as deemed proper by the Executive Committee.

C. To have and exercise all other powers and authority now or hereafter conferred upon not-for-profit corporations under the laws of the State of Illinois, (USA).

D. No part of the net earnings of the ISR shall inure to the benefit of, or be distributable to, its officers, directors, members or other private persons, except that the ISR shall be authorized and empowered to pay reasonable compensation for services rendered and to make payments and distributions in furtherance of the purposes set forth in this section.

The activities of the entity are related to the following strategic priorities and outcomes of the current WHO's General Programme of Work:

Strategic objective 1: Respond to climate change, an escalating health threat in the 21st century

Joint outcome 1.1. More climate-resilient health systems are addressing health risks and impacts

Joint outcome 1.2. Lower-carbon health systems and societies are contributing to health and well-being

Strategic objective 2: Address health determinants and the root causes of ill health in key policies across sectors

Joint outcome 2.1. Health inequities reduced by acting on social, economic, environmental and other determinants of health

Joint outcome 2.2. Priority risk factors for noncommunicable and communicable diseases, violence and injury, and poor nutrition, reduced through multisectoral approaches

Joint outcome 2.3. Populations empowered to control their health through health promotion programmes and community involvement in decision-making

Strategic objective 3: Advance the primary health care approach and essential health system capacities for universal health coverage

Joint outcome 3.1. The primary health care approach renewed and strengthened to accelerate universal health coverage

Joint outcome 3.2. Health and care workforce, health financing and access to quality-assured health products substantially improved

Joint outcome 3.3. Health information systems strengthened and digital transformation implemented.

Strategic objective 4: Improve health service coverage and financial protection to address inequity and gender inequalities

Joint outcome 4.1. Equity in access to quality services improved for noncommunicable diseases, mental health conditions and communicable diseases, while addressing antimicrobial resistance

Joint outcome 4.2. Equity in access to sexual, reproductive, maternal, newborn, child, adolescent and older person health and nutrition services and immunization coverage improved

Joint outcome 4.3. Financial protection improved by reducing financial barriers and out-of-pocket health expenditures, especially for the most vulnerable

Strategic objective 5: Prevent, mitigate and prepare for risks to health from all hazards

Joint outcome 5.1. Risks of health emergencies from all hazards reduced and impact mitigated

Joint outcome 5.2. Preparedness, readiness and resilience for health emergencies enhanced

Strategic objective 6: Rapidly detect and sustain an effective response to all health emergencies

Joint outcome 6.1. Detection of and response to acute public health threats is rapid and effective

Joint outcome 6.2. Access to essential health services during emergencies is sustained and equitable

Additional information on the entity's activities

Country presence

Countries where the entity has activities, members and regional offices / representatives:

Regions

Countries

Activities

Members

Offices / representatives

African Region

Region of the Americas

Eastern Mediterranean Region

European Region

South-East Asia Region

Western Pacific Region

Global

Disclosure & declaration

Tobacco/Arms related disclosure statement for non-State actors

Pursuant the WHO Framework of Engagement with Non-State Actors, WHO does not engage with the tobacco industry or non-State actors that work to further the interests of the tobacco industry. WHO also does not engage with the arms industry.

For the purposes of this statement:

tobacco industry means any entity involved in the manufacture, sale or distribution of tobacco and related products, and any affiliate of such entity; and
arms industry means any entity involved in the manufacture, sale or distribution of arms, and any affiliate of such entity.

This disclosure statement needs to be provided by any nongovernmental organization, private sector entity, philanthropic foundation and academic institution prior to engaging with WHO.

In view of the foregoing, please answer the following questions:

Is your entity, or was your entity over the last four years, part of the tobacco or arms industries (as defined above)?

Yes

No

Unable to answer

To the best of your entity’s knowledge, is your entity, or has your entity over the last four years, engaged in activities that are aimed at furthering or supporting the interests of the tobacco industry? This includes, but is not limited to, supply contracts, contract work, services and lobbying.

Yes

No

Unable to answer

To the best of your entity’s knowledge, does your entity currently, or did your entity over the last four years, have any other association or relationship with the tobacco industry (as defined above). This includes in particular investment interests (other than general mutual funds or similar arrangements whereby your entity has no control over the selection of the investments), commercial business interests, the provision or receipt of financial and/or other support.

Yes

No

Unable to answer

If you have answered yes to any of the above or are unable to answer one or more questions, please provide a general statement of explanation.

Please note that the WHO Secretariat reserves the right to request additional information from your entity in this regard.

By providing this statement, your entity commits to promptly inform WHO of any change to the above information and to complete a new statement that describes the changes.

Engagement with other industries affecting human health or affected by WHO norm and standards

Does the entity you represent have any formal association, affiliation or links with the following industry sectors?

If yes, please tick the box of the industry concerned and provide details in the space provided:

Alcohol

Chemical

Food and beverages

Health care

Pharmaceutical

Others

Please specify industry

WHO Secretariat reserves the right to request additional information from the entity you represent relevant to its engagement with WHO.

*Sexual Exploitation, Abuse and Harassment (SEAH) and Misconduct (abusive or fraudulent)

Entities engaging with WHO are expected to ensure that the conduct of their employees and any other persons engaged by them to perform any activities or to provide any services for WHO on behalf of the entities is consistent with the WHO standards of conduct. In particular, WHO has zero tolerance towards any form of sexual misconduct, which includes sexual exploitation, sexual abuse, sexual violence, and sexual harassment, and other types of abusive or fraudulent conduct. In the view of the forgoing, please confirm that your entity shall:

Take all reasonable and appropriate measures to prevent sexual misconduct as defined in WHO’s Policy on Preventing and Addressing Sexual Misconduct, and other types of abusive or fraudulent conduct as defined, respectively, in WHO’s Policy on Preventing and Addressing Abusive Conduct and in WHO’s Policy on Prevention, Detection and Response to Fraud and Corruption by any of its employees and by any other persons engaged by it to perform any activities or to provide any services for WHO on the entity’s behalf;

Promptly report to WHO’s Office of Internal Oversight Services (IOS) at investigation@who.int any actual or suspected misconduct, as defined by WHO in these Policies and of which the entity becomes aware;

Promptly communicate to IOS any measures that may be necessary or appropriate to protect the confidentiality and wellbeing of the alleged victim;

Promptly respond to any actual or suspected misconduct as defined by WHO in these Policies of which the entity becomes aware; and

To cooperate with IOS and keep IOS informed of the status and outcome of any measures of protection, corrections to operations, investigation, and disciplinary action taken against any perpetrator by the entity.

Date submitted